Antibacterial potential of Euphorbia canariensis against Pseudomonas aeruginosa bacteria causing respiratory tract infections

References

• Qin S, Xiao W, Zhou C, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199. doi: 10.1038/s41392-022-01056-1.
   PubMed Web of Science ®Google Scholar
• Tuon FF, Dantas LR, Suss PH, et al. Pathogenesis of the Pseudomonas aeruginosa biofilm: a review. Pathogens. 2022;11(3):300. doi: 10.3390/pathogens11030300.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0.
   PubMed Web of Science ®Google Scholar
• Kunz Coyne AJ, El Ghali A, Holger D, et al. Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa. Infect Dis Ther. 2022;11(2):661–682. doi: 10.1007/s40121-022-00591-2.
   PubMed Web of Science ®Google Scholar
• Serwecińska L. Antimicrobials and antibiotic-resistant bacteria: a risk to the environment and to public health. Water. 2020;12(12):3313. doi: 10.3390/w12123313.
   Web of Science ®Google Scholar
• Aziz E, Batool R, Akhtar W, et al. Rosemary species: a review of phytochemicals, bioactivities and industrial applications. S Afr J Bot. 2022;151:3–18. doi: 10.1016/j.sajb.2021.09.026.
   Web of Science ®Google Scholar
• Adnan M, Rasul A, Hussain G, et al. Ginkgetin: a natural biflavone with versatile pharmacological activities. Food Chem Toxicol. 2020;145:111642. doi: 10.1016/j.fct.2020.111642.
   PubMed Web of Science ®Google Scholar
• Zhao H, Sun L, Kong C, et al. Phytochemical and pharmacological review of diterpenoids from the genus euphorbia linn (2012–2021). J Ethnopharmacol. 2022;298:115574. doi: 10.1016/j.jep.2022.115574.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tang P, Zhu M, et al. Diterpenoids from the genus euphorbia: structure and biological activity (2013–2019). Phytochemistry. 2021;190:112846. doi: 10.1016/j.phytochem.2021.112846.
   PubMed Web of Science ®Google Scholar
• Jassbi AR. Chemistry and biological activity of secondary metabolites in euphorbia from Iran. Phytochemistry. 2006;67(18):1977–1984. doi: 10.1016/j.phytochem.2006.06.030.
   PubMed Web of Science ®Google Scholar
• Chamkhi I, Hnini M, Aurag J. Conventional medicinal uses, phytoconstituents, and biological activities of euphorbia officinarum L.: a systematic review. Adv Pharmacol Pharm Sci. 2022;2022:9971085–9971089. doi: 10.1155/2022/9971085.
   PubMedGoogle Scholar
• Amtaghri S, Akdad M, Slaoui M, et al. Traditional uses, pharmacological, and phytochemical studies of euphorbia: a review. Curr Top Med Chem. 2022;22(19):1553–1570. doi: 10.2174/1568026622666220713143436.
   PubMed Web of Science ®Google Scholar
• Miranda FJ, Alabadí JA, Ortí M, et al. Comparative analysis of the vascular actions of diterpenes isolated from euphorbia canariensis. J Pharm Pharmacol. 1998;50(2):237–241. doi: 10.1111/j.2042-7158.1998.tb06182.x.
   PubMed Web of Science ®Google Scholar
• Vaou N, Stavropoulou E, Voidarou C, et al. Towards advances in medicinal plant antimicrobial activity: a review study on challenges and future perspectives. Microorganisms. 2021;9(10):2041. doi: 10.3390/microorganisms9102041.
   PubMed Web of Science ®Google Scholar
• Gonelimali FD, Lin J, Miao W, et al. Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front Microbiol. 2018;9:1639. doi: 10.3389/fmicb.2018.01639.
   PubMed Web of Science ®Google Scholar
• Mostafa AA, Al-Askar AA, Almaary KS, et al. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci. 2018;25(2):361–366. doi: 10.1016/j.sjbs.2017.02.004.
   PubMed Web of Science ®Google Scholar
• Hemeg HA, Moussa IM, Ibrahim S, et al. Antimicrobial effect of different herbal plant extracts against different microbial population. Saudi J Biol Sci. 2020;27(12):3221–3227. doi: 10.1016/j.sjbs.2020.08.015.
   PubMed Web of Science ®Google Scholar
• El-Hawary SS, Mohammed R, Tawfike AF, et al. Cytotoxic activity and metabolic profiling of fifteen euphorbia species. Metabolites. 2020;11(1):15. doi: 10.3390/metabo11010015.
   PubMed Web of Science ®Google Scholar
• Banar M, Emaneini M, Satarzadeh M, et al. Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections. PLoS One. 2016;11(10):e0164622. doi: 10.1371/journal.pone.0164622.
   PubMed Web of Science ®Google Scholar
• Ansar W, Ghosh S. Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biology of C Reactive Protein in Health and Disease. 2016;20:67–107.
   Google Scholar
• Ning Q, Wu D, Wang X, et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther. 2022;7(1):57. doi: 10.1038/s41392-022-00907-1.
   PubMed Web of Science ®Google Scholar
• Bhatt D, Ghosh S. Regulation of the NF-κB-mediated transcription of inflammatory genes. Front Immunol. 2014;5:71. doi: 10.3389/fimmu.2014.00071.
   PubMed Web of Science ®Google Scholar
• Jorgensen I, Rayamajhi M, Miao EA. Programmed cell death as a defence against infection. Nat Rev Immunol. 2017;17(3):151–164. doi: 10.1038/nri.2016.147.
   PubMed Web of Science ®Google Scholar
• Yu X, He S. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J. 2016;13(1):77. doi: 10.1186/s12985-016-0528-0.
   PubMedGoogle Scholar
• Sharifi-Rad M, Anil Kumar NV, Zucca P, et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol. 2020;11:694. doi: 10.3389/fphys.2020.00694.
   PubMed Web of Science ®Google Scholar
• Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. doi: 10.3390/ijms20236008.
   PubMed Web of Science ®Google Scholar
• Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871–891. doi: 10.1016/j.immuni.2019.03.020.
   PubMed Web of Science ®Google Scholar
• Attallah NG, El-Sherbeni SA, El-Kadem AH, et al. Elucidation of the metabolite profile of yucca gigantea and assessment of its cytotoxic, antimicrobial, and anti-inflammatory activities. Molecules. 2022;27(4):1329. doi: 10.3390/molecules27041329.
   PubMed Web of Science ®Google Scholar
• Alotaibi B, El-Masry TA, Elekhnawy E, et al. Aqueous core epigallocatechin gallate PLGA nanocapsules: characterization, antibacterial activity against uropathogens, and in vivo reno-protective effect in cisplatin induced nephrotoxicity. Drug Deliv. 2022;29(1):1848–1862. doi: 10.1080/10717544.2022.2083725.
   PubMed Web of Science ®Google Scholar
• Elekhnawy E, Sonbol F, Abdelaziz A, et al. An investigation of the impact of triclosan adaptation on Proteus mirabilis clinical isolates from an egyptian university hospital. Braz J Microbiol. 2021;52(2):927–937. doi: 10.1007/s42770-021-00485-4.
   PubMed Web of Science ®Google Scholar
• Attallah NG, Negm WA, Elekhnawy E, et al. Antibacterial activity of boswellia sacra flueck. Oleoresin extract against Porphyromonas gingivalis periodontal pathogen. Antibiotics. 2021;10(7):859. doi: 10.3390/antibiotics10070859.
   Google Scholar
• Attallah NG, Al-Fakhrany OM, Elekhnawy E, et al. Anti-biofilm and antibacterial activities of cycas media R. Br secondary metabolites: in silico, in vitro, and in vivo approaches. Antibiotics. 2022;11(8):993. doi: 10.3390/antibiotics11080993.
   Google Scholar
• Abdel Bar FM, Alossaimi MA, Elekhnawy E, et al. Anti-Quorum sensing and anti-biofilm activity of pelargonium × hortorum root extract against Pseudomonas aeruginosa: combinatorial effect of catechin and gallic acid. Molecules. 2022;27(22):7841. doi: 10.3390/molecules27227841.
   PubMed Web of Science ®Google Scholar
• Alomair BM, Al-Kuraishy HM, Al-Buhadily AK, et al. Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Inflammopharmacology. 2022;30(6):2411–2415. doi: 10.1007/s10787-022-01078-9.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Binsuwaidan R, Sultan AA, Negm WA, et al. Bilosomes as nanoplatform for oral delivery and modulated in vivo antimicrobial activity of lycopene. Pharmaceuticals. 2022;15(9):1043. doi: 10.3390/ph15091043.
   Web of Science ®Google Scholar
• Alherz FA, Negm WA, Elekhnawy E, et al. Silver nanoparticles prepared using encephalartos laurentianus De wild leaf extract have inhibitory activity against Candida albicans clinical isolates. JoF. 2022;8(10):1005. doi: 10.3390/jof8101005.
   Google Scholar
• Al-Kuraishy HM, Al-Gareeb AI, Albogami SM, et al. Potential therapeutic benefits of metformin alone and in combination with sitagliptin in the management of type 2 diabetes patients with COVID-19. Pharmaceuticals. 2022;15(11):1361. doi: 10.3390/ph15111361.
   Web of Science ®Google Scholar
• Wang M, Weng X, Chen H, et al. Resveratrol inhibits TNF-α-induced inflammation to protect against renal ischemia/reperfusion injury in diabetic rats. Acta Cir Bras. 2020;35(5):219. doi: 10.1590/s0102-865020200050000006.
   Web of Science ®Google Scholar
• Batiha GE-S, Al-Gareeb AI, Elekhnawy E, et al. Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacology. 2022;30(6):1993–2001. doi: 10.1007/s10787-022-01070-3.
   PubMed Web of Science ®Google Scholar